ID SAMD8_HUMAN Reviewed; 415 AA. AC Q96LT4; Q5JSC5; Q5JSC8; Q66K52; DT 01-MAR-2004, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2004, sequence version 2. DT 24-JAN-2024, entry version 168. DE RecName: Full=Sphingomyelin synthase-related protein 1 {ECO:0000305}; DE Short=SMSr; DE EC=2.7.8.- {ECO:0000269|PubMed:19506037}; DE AltName: Full=Ceramide phosphoethanolamine synthase; DE Short=CPE synthase; DE AltName: Full=Sterile alpha motif domain-containing protein 8; DE Short=SAM domain-containing protein 8; GN Name=SAMD8 {ECO:0000312|HGNC:HGNC:26320}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606 {ECO:0000312|EMBL:BAB71586.1}; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Huitema K.; RL Submitted (FEB-2003) to UniProtKB. RN [2] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Cerebellum {ECO:0000312|EMBL:BAB71586.1}; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164054; DOI=10.1038/nature02462; RA Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., RA Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., RA Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., RA Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P., RA Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., RA Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., RA Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., RA Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., RA Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., RA Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., RA Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., RA Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., RA Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., RA McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., RA Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., RA Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., RA Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., RA Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., RA Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., RA Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., RA Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., RA Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 10."; RL Nature 429:375-381(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] OF 198-359 (ISOFORM 1). RA Ebert L., Heil O., Hennig S., Neubert P., Partsch E., Peters M., RA Radelof U., Schneider D., Korn B.; RL Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases. RN [7] {ECO:0000305} RP IDENTIFICATION. RX PubMed=14685263; DOI=10.1038/sj.emboj.7600034; RA Huitema K., Van Den Dikkenberg J., Brouwers J.F.H.M., Holthuis J.C.; RT "Identification of a family of animal sphingomyelin synthases."; RL EMBO J. 23:33-44(2004). RN [8] RP SUBSTRATE SPECIFICITY, SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF RP ASP-348, IDENTIFICATION BY MASS SPECTROMETRY, AND CATALYTIC ACTIVITY. RX PubMed=19506037; DOI=10.1083/jcb.200903152; RA Vacaru A.M., Tafesse F.G., Ternes P., Kondylis V., Hermansson M., RA Brouwers J.F., Somerharju P., Rabouille C., Holthuis J.C.; RT "Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis RT in the ER."; RL J. Cell Biol. 185:1013-1027(2009). CC -!- FUNCTION: Sphingomyelin synthases synthesize sphingolipids through CC transfer of a phosphatidyl head group on to the primary hydroxyl of CC ceramide. SAMD8 is an endoplasmic reticulum (ER) transferase that has CC no sphingomyelin synthase activity but can convert CC phosphatidylethanolamine (PE) and ceramide to ceramide CC phosphoethanolamine (CPE) albeit with low product yield. Appears to CC operate as a ceramide sensor to control ceramide homeostasis in the CC endoplasmic reticulum rather than a converter of ceramides. Seems to be CC critical for the integrity of the early secretory pathway. CC {ECO:0000269|PubMed:19506037}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + N- CC hexadecanoylsphinganine = a 1,2-diacyl-sn-glycerol + N-hexadecanoyl- CC sphinganine-1-phosphoethanolamine; Xref=Rhea:RHEA:42128, CC ChEBI:CHEBI:17815, ChEBI:CHEBI:64612, ChEBI:CHEBI:67042, CC ChEBI:CHEBI:78654; Evidence={ECO:0000269|PubMed:19506037}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42129; CC Evidence={ECO:0000305|PubMed:19506037}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine + N- CC hexadecanoyl-(4R)-hydroxysphinganine = a 1,2-diacyl-sn-glycerol + N- CC hexadecanoyl-(4R)-hydroxysphinganine-1-phosphoethanolamine; CC Xref=Rhea:RHEA:42144, ChEBI:CHEBI:17815, ChEBI:CHEBI:64612, CC ChEBI:CHEBI:65107, ChEBI:CHEBI:78656; CC Evidence={ECO:0000269|PubMed:19506037}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42145; CC Evidence={ECO:0000305|PubMed:19506037}; CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:19506037}; Multi-pass membrane protein CC {ECO:0000269|PubMed:19506037}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q96LT4-1; Sequence=Displayed; CC Name=2; CC IsoId=Q96LT4-2; Sequence=VSP_038403, VSP_038404; CC -!- DOMAIN: The SAM domain is required to retain SMAD8 in the endoplasmic CC reticulum. CC -!- SIMILARITY: Belongs to the sphingomyelin synthase family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH80593.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK057811; BAB71586.1; -; mRNA. DR EMBL; AL392111; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471083; EAW54566.1; -; Genomic_DNA. DR EMBL; CH471083; EAW54567.1; -; Genomic_DNA. DR EMBL; BC080593; AAH80593.1; ALT_INIT; mRNA. DR EMBL; BX280496; -; NOT_ANNOTATED_CDS; mRNA. DR CCDS; CCDS53543.1; -. [Q96LT4-1] DR CCDS; CCDS7347.1; -. [Q96LT4-2] DR RefSeq; NP_001167627.1; NM_001174156.1. [Q96LT4-1] DR RefSeq; NP_653261.1; NM_144660.2. [Q96LT4-2] DR RefSeq; XP_005269598.1; XM_005269541.4. [Q96LT4-1] DR RefSeq; XP_011537613.1; XM_011539311.1. DR RefSeq; XP_011537614.1; XM_011539312.2. [Q96LT4-1] DR RefSeq; XP_016871228.1; XM_017015739.1. DR AlphaFoldDB; Q96LT4; -. DR SMR; Q96LT4; -. DR BioGRID; 126778; 8. DR IntAct; Q96LT4; 4. DR STRING; 9606.ENSP00000500411; -. DR SwissLipids; SLP:000000704; -. DR iPTMnet; Q96LT4; -. DR PhosphoSitePlus; Q96LT4; -. DR SwissPalm; Q96LT4; -. DR BioMuta; SAMD8; -. DR DMDM; 44888529; -. DR EPD; Q96LT4; -. DR jPOST; Q96LT4; -. DR MassIVE; Q96LT4; -. DR MaxQB; Q96LT4; -. DR PaxDb; 9606-ENSP00000438042; -. DR PeptideAtlas; Q96LT4; -. DR ProteomicsDB; 77245; -. [Q96LT4-1] DR ProteomicsDB; 77246; -. [Q96LT4-2] DR Antibodypedia; 29663; 128 antibodies from 23 providers. DR DNASU; 142891; -. DR Ensembl; ENST00000372687.4; ENSP00000361772.3; ENSG00000156671.15. [Q96LT4-2] DR Ensembl; ENST00000542569.6; ENSP00000438042.1; ENSG00000156671.15. [Q96LT4-1] DR Ensembl; ENST00000671800.1; ENSP00000500411.1; ENSG00000156671.15. [Q96LT4-1] DR GeneID; 142891; -. DR KEGG; hsa:142891; -. DR MANE-Select; ENST00000542569.6; ENSP00000438042.1; NM_001174156.2; NP_001167627.1. DR UCSC; uc001jwx.2; human. [Q96LT4-1] DR AGR; HGNC:26320; -. DR CTD; 142891; -. DR DisGeNET; 142891; -. DR GeneCards; SAMD8; -. DR HGNC; HGNC:26320; SAMD8. DR HPA; ENSG00000156671; Low tissue specificity. DR MIM; 611575; gene. DR neXtProt; NX_Q96LT4; -. DR OpenTargets; ENSG00000156671; -. DR PharmGKB; PA134868247; -. DR VEuPathDB; HostDB:ENSG00000156671; -. DR eggNOG; KOG3058; Eukaryota. DR GeneTree; ENSGT00940000155540; -. DR HOGENOM; CLU_027104_1_1_1; -. DR InParanoid; Q96LT4; -. DR OrthoDB; 1343173at2759; -. DR PhylomeDB; Q96LT4; -. DR TreeFam; TF314547; -. DR PathwayCommons; Q96LT4; -. DR Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis. DR SignaLink; Q96LT4; -. DR BioGRID-ORCS; 142891; 9 hits in 1155 CRISPR screens. DR ChiTaRS; SAMD8; human. DR GenomeRNAi; 142891; -. DR Pharos; Q96LT4; Tbio. DR PRO; PR:Q96LT4; -. DR Proteomes; UP000005640; Chromosome 10. DR RNAct; Q96LT4; Protein. DR Bgee; ENSG00000156671; Expressed in medial globus pallidus and 189 other cell types or tissues. DR ExpressionAtlas; Q96LT4; baseline and differential. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB. DR GO; GO:0016020; C:membrane; NAS:UniProtKB. DR GO; GO:0047493; F:ceramide cholinephosphotransferase activity; IBA:GO_Central. DR GO; GO:0002950; F:ceramide phosphoethanolamine synthase activity; TAS:Reactome. DR GO; GO:0033188; F:sphingomyelin synthase activity; IBA:GO_Central. DR GO; GO:0046513; P:ceramide biosynthetic process; IDA:UniProtKB. DR GO; GO:1905373; P:ceramide phosphoethanolamine biosynthetic process; IEA:Ensembl. DR GO; GO:2000303; P:regulation of ceramide biosynthetic process; IDA:UniProtKB. DR GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome. DR GO; GO:0006686; P:sphingomyelin biosynthetic process; NAS:UniProtKB. DR CDD; cd09515; SAM_SGMS1-like; 1. DR Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1. DR InterPro; IPR001660; SAM. DR InterPro; IPR013761; SAM/pointed_sf. DR InterPro; IPR045221; Sphingomyelin_synth-like. DR InterPro; IPR025749; Sphingomyelin_synth-like_dom. DR PANTHER; PTHR21290:SF25; SPHINGOMYELIN SYNTHASE-RELATED PROTEIN 1; 1. DR PANTHER; PTHR21290; SPHINGOMYELIN SYNTHETASE; 1. DR Pfam; PF14360; PAP2_C; 1. DR Pfam; PF00536; SAM_1; 1. DR SMART; SM00454; SAM; 1. DR SUPFAM; SSF47769; SAM/Pointed domain; 1. DR PROSITE; PS50105; SAM_DOMAIN; 1. DR Genevisible; Q96LT4; HS. PE 1: Evidence at protein level; KW Alternative splicing; Endoplasmic reticulum; Lipid metabolism; Membrane; KW Reference proteome; Sphingolipid metabolism; Transferase; Transmembrane; KW Transmembrane helix. FT CHAIN 1..415 FT /note="Sphingomyelin synthase-related protein 1" FT /id="PRO_0000221080" FT TRANSMEM 153..173 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 201..221 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 232..252 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 277..297 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 322..342 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 347..367 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 368..415 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 12..78 FT /note="SAM" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00184" FT ACT_SITE 301 FT /evidence="ECO:0000250" FT ACT_SITE 344 FT /evidence="ECO:0000250" FT ACT_SITE 348 FT VAR_SEQ 315..326 FT /note="YTPRSWNFLHTL -> CKYLFSASMRIR (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_038403" FT VAR_SEQ 327..415 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_038404" FT MUTAGEN 348 FT /note="D->E: Abolishes CPE synthase activity." FT /evidence="ECO:0000269|PubMed:19506037" SQ SEQUENCE 415 AA; 48321 MW; AAED366F56C9CDC9 CRC64; MAGPNQLCIR RWTTKHVAVW LKDEGFFEYV DILCNKHRLD GITLLTLTEY DLRSPPLEIK VLGDIKRLML SVRKLQKIHI DVLEEMGYNS DSPMGSMTPF ISALQSTDWL CNGELSHDCD GPITDLNSDQ YQYMNGKNKH SVRRLDPEYW KTILSCIYVF IVFGFTSFIM VIVHERVPDM QTYPPLPDIF LDSVPRIPWA FAMTEVCGMI LCYIWLLVLL LHKHRSILLR RLCSLMGTVF LLRCFTMFVT SLSVPGQHLQ CTGKIYGSVW EKLHRAFAIW SGFGMTLTGV HTCGDYMFSG HTVVLTMLNF FVTEYTPRSW NFLHTLSWVL NLFGIFFILA AHEHYSIDVF IAFYITTRLF LYYHTLANTR AYQQSRRARI WFPMFSFFEC NVNGTVPNEY CWPFSKPAIM KRLIG //